CEO
A highly accomplished executive with more than three decades of experience in the pharmaceutical industry, specialising in strategic planning, business development, and organisational leadership — with a proven track record in managing large-scale operations and driving remarkable sales growth across Saudi Arabia.
A highly accomplished executive with more than three decades of experience in the pharmaceutical industry, specializing in strategic planning, business development, and organizational leadership. Proven track record in managing large-scale operations, driving sales growth from SAR 100 million in 2008 to over SAR 1 billion in 2025, and achieving operational excellence. Adept at fostering strong relationships with internal teams and external stakeholders to ensure alignment with corporate objectives.
Develops the company strategy and monitors its execution with all relevant departments — presenting it to the Board of Directors for approval before implementation and ensuring every division is aligned with corporate objectives.
Oversees coordination between all branches, administrative levels, and functional departments across the Kingdom to ensure unified and aligned operations.
Upholds company policy as approved by the Board of Directors and maintains full accountability for all signed decisions, contracts, and approved records.
Oversees and supervises all financial and commercial activities — including cash flow management, banking relationships, purchasing, inventory, and revenue — with full accountability to the Board for commercial performance.
Supervises full compliance with SFDA, GDP, GMP, and ISO standards across all warehouses, distribution channels, and partner contracts throughout the Kingdom.
Leads negotiations and approves all major supplier contracts, principal agreements, and government tender submissions for MOH, NUPCO, and Etimad.
Khalid Abdelatif Youssef Ali holds a PHD in Business Administration from Helwan University, an Executive Master of Business Administration (EMBA) from Alexandria University, and a Bachelor of Law (LLB) from Ain Shams University. With more than three decades of experience in the pharmaceutical industry, he was personally selected by company founder Sheikh Yousuf Jamjoom to serve as CEO of Jamjoom Medicine Store upon the founder's retirement in 2008 — entrusted with full executive authority.
Under his leadership, the company's revenues grew from SAR 100 million in 2008 to surpassing SAR 1 billion in 2025 — a testament to his strategic vision and operational expertise. He is the primary bridge between Board-level direction and day-to-day operational execution across JMS's full nationwide network.